Patents by Inventor Ismail Fliss
Ismail Fliss has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230337702Abstract: A process for the linear synthesis of a gram-positive class II bacteriocin or a variant thereof is disclosed herein. The process comprises the stepwise addition of selected amino acids to a solid support; pseudoproline positioning and reopening; and cleavage of the gram-positive class II bacteriocin or the variant thereof from the solid support to provide a linear gram-positive class II bacteriocin or variant thereof; and in situ disulfide bond formation. Various applications and uses of the synthetic bacteriocins are also disclosed. The synthetic process can also be used to synthesize variants of bacteriocins by the selective substitution of one or more amino acids and/or additions and/or deletions of selected amino acids.Type: ApplicationFiled: December 22, 2022Publication date: October 26, 2023Inventors: François Bédard, Éric Biron, Riadh Hammami, Ismail Fliss, Ariane RENAUD, Laurent DALLAIRE
-
Patent number: 11571456Abstract: A process for the linear synthesis of a gram-positive class II bacteriocin or a variant thereof is disclosed herein. The process comprises the stepwise addition of selected amino acids to a solid support; pseudoproline positioning and reopening; and cleavage of the gram-positive class II bacteriocin or the variant thereof from the solid support to provide a linear gram-positive class II bacteriocin or variant thereof; and in situ disulfide bond formation. Various applications and uses of the synthetic bacteriocins are also disclosed. The synthetic process can also be used to synthesize variants of bacteriocins by the selective substitution of one or more amino acids and/or additions and/or deletions of selected amino acids.Type: GrantFiled: May 23, 2018Date of Patent: February 7, 2023Assignee: UNIVERSITÉ LAVALInventors: François Bédard, Éric Biron, Riadh Hammami, Ismail Fliss
-
Publication number: 20210023168Abstract: A process for the linear synthesis of a gram-positive class II bacteriocin or a variant thereof is disclosed herein. The process comprises the stepwise addition of selected amino acids to a solid support; pseudoproline positioning and reopening; and cleavage of the gram-positive class II bacteriocin or the variant thereof from the solid support to provide a linear gram-positive class II bacteriocin or variant thereof; and in situ disulfide bond formation. Various applications and uses of the synthetic bacteriocins are also disclosed. The synthetic process can also be used to synthesize variants of bacteriocins by the selective substitution of one or more amino acids and/or additions and/or deletions of selected amino acids.Type: ApplicationFiled: May 23, 2018Publication date: January 28, 2021Inventors: François Bédard, Éric Biron, Riadh Hammami, Ismail Fliss
-
Publication number: 20170303539Abstract: The present invention relates to an antimicrobial composition having activity against Gram-positive and Gram-negative bacteria. The composition is a) a composition comprising at least two organic acids selected from the group consisting of lactic acid, acetic acid, benzoic acid and citric acid; b) a composition comprising at least two bacteriocin selected from the group consisting of pediocin, Nisin and reuterin; c) a composition comprising pediocin and at least two organic acids selected from the group consisting of lactic acid, acetic acid, benzoic acid and citric acid; or d) a composition comprising reuterin and at least one organic acid selected from the group consisting of lactic acid, acetic acid, benzoic acid and citric acid. The present invention also relates to the use of said compositions for sanitizing and/or disinfecting surfaces and method thereof.Type: ApplicationFiled: May 8, 2017Publication date: October 26, 2017Applicant: CASCADES CANADA ULCInventors: Ismail Fliss, Pierre Hudon, Marie-Helene Charest, Nathalie Comeau
-
Patent number: 9642362Abstract: The present invention relates to an antimicrobial composition having activity against Gram-positive and Gram-negative bacteria. The composition is a) a composition comprising at least two organic acids selected from the group consisting of lactic acid, acetic acid, benzoic acid and citric acid; b) a composition comprising at least two bacteriocin selected from the group consisting of pediocin, Nisin and reuterin; c) a composition comprising pediocin and at least two organic acids selected from the group consisting of lactic acid, acetic acid, benzoic acid and citric acid; or d) a composition comprising reuterin and at least one organic acid selected from the group consisting of lactic acid, acetic acid, benzoic acid and citric acid. The present invention also relates to the use of said compositions for sanitizing and/or disinfecting surfaces and method thereof.Type: GrantFiled: April 15, 2013Date of Patent: May 9, 2017Assignee: CASCADES CANADA ULCInventors: Ismail Fliss, Pierre Hudon, Marie-Helene Charest, Nathalie Comeau
-
Publication number: 20150072920Abstract: The present invention relates to an antimicrobial composition having activity against Gram-positive and Gram-negative bacteria. The composition is a) a composition comprising at least two organic acids selected from the group consisting of lactic acid, acetic acid, benzoic acid and citric acid; b) a composition comprising at least two bacteriocin selected from the group consisting of pediocin, Nisin and reuterin; c) a composition comprising pediocin and at least two organic acids selected from the group consisting of lactic acid, acetic acid, benzoic acid and citric acid; or d) a composition comprising reuterin and at least one organic acid selected from the group consisting of lactic acid, acetic acid, benzoic acid and citric acid. The present invention also relates to the use of said compositions for sanitizing and/or disinfecting surfaces and method thereof.Type: ApplicationFiled: April 15, 2013Publication date: March 12, 2015Applicant: CASCADES CANADA ULCInventors: Ismail Fliss, Pierre Hudon, Marie-Helene Charest, Nathalie Comeau
-
Patent number: 8551543Abstract: The present invention relates to novel maple product compositions. In particular, the present invention relates to new compositions comprising maple sap, maple concentrate, maple syrup or diluted maple syrup, and probiotics, prebiotics or combinations thereof. The present invention also discloses methods for the production of maple based products, including functional drinks, comprising a composition comprising maple sap, maple concentrate, maple syrup or dilutated maple syrup, and probiotics, prebiotics or combinations thereof, as a vehicle for the delivery of probiotics and prebiotics to the gastrointestinal tract.Type: GrantFiled: March 5, 2010Date of Patent: October 8, 2013Assignee: Fédération des Producteurs Acéricoles du QuébecInventors: Geneviève Béland, Julie Barbeau, Ismail Fliss
-
Publication number: 20120027735Abstract: The present invention relates to novel maple product compositions. In particular, the present invention relates to new compositions comprising maple sap, maple concentrate, maple syrup or diluted maple syrup, and probiotics, prebiotics or combinations thereof. The present invention also discloses methods for the production of maple based products, including functional drinks, comprising a composition comprising maple sap, maple concentrate, maple syrup or dilutated maple syrup, and probiotics, prebiotics or combinations thereof, as a vehicle for the delivery of probiotics and prebiotics to the gastrointestinal tract.Type: ApplicationFiled: March 5, 2010Publication date: February 2, 2012Applicant: Federation des producteurs acericoles du QuebecInventors: Geneviève Béland, Julie Barbeau, Ismail Fliss
-
Publication number: 20090297545Abstract: The present invention provide a new method for modulating the immune system of a subject in need thereof by administering a dairy-derived peptide to the subject, particularly a ?-lactoglubulin-derived peptide (?-Lg peptide). According to one aspect, the modulation of the immune system is the modulation of a Th1 response. According to another aspect, the modulation of the immune system is the modulation of a Th2 response.Type: ApplicationFiled: May 27, 2009Publication date: December 3, 2009Applicant: Universite LavalInventors: Sylvie Gauthier, Yvan Boutin, Arnaud Jacquot, Diane Saint-Sauveur, Réjean Drouin, Ismail Fliss
-
Publication number: 20080152775Abstract: The present invention relates to a process using dynamic high-pressure for inactivation of food pathogens. Liquid food are treated by dynamic-high-pressure at 1 to 5 kbars with at least one recirculation depending on the needs. The pasteurization process is performed at relatively cold temperature ranging from 4° C. to 55° C.Type: ApplicationFiled: May 9, 2007Publication date: June 26, 2008Applicant: UNIVERSITE LAVALInventors: Paul Paquin, Jocelyne Giasson, Jean-Francois Vachon, Ismail Fliss
-
Patent number: 7247306Abstract: The present invention concerns an isolated bacteriocin, Divergicin M35, derived form Carnobacterium divergens M35. It also concerns a composition comprising an effective amount of Divergicin M35 and the use of that bacteriocin to kill or limit the proliferation of a microorganism.Type: GrantFiled: April 30, 2004Date of Patent: July 24, 2007Assignee: Universite LavalInventors: Ismail Fliss, Michel Desbiens, Christophe Lacroix, Imane Tahiri, Régis-Olivier Benech, Ehab Kheadr
-
Patent number: 7182943Abstract: A method and a system is disclosed for the modulation of various characteristics of probiotic cells and for the production of probiotics having altered characteristics. Such altered characteristics include increased resistance to various stresses, drugs and chemical agents, as well as aggregation. Such a method and a system are useful for the production of probiotics with altered characteristics, which may for example provide health benefits when present in the gastrointestinal tract of an animal.Type: GrantFiled: May 14, 2003Date of Patent: February 27, 2007Assignee: Université LavalInventors: Christophe Lacroix, Ismail Fliss, Yann Doleyres, Dirk Bergmaier
-
Publication number: 20050245443Abstract: The present invention concerns an isolated bacteriocin, Divergicin M35, derived form Carnobacterium divergens M35. It also concerns a composition comprising an effective amount of Divergicin M35 and the use of that bacteriocin to kill or limit the proliferation of a microorganism.Type: ApplicationFiled: April 30, 2004Publication date: November 3, 2005Applicants: UNIVERSITE LAVAL, MINISTERE DE L'AGRICULTURE, DES PECHERIES ET DE L'ALIMENTATIONInventors: Ismail Fliss, Michel Desbiens, Christophe Lacroix, Imane Tahiri, Regis-Olivier Benech, Ehab Kheadr
-
Publication number: 20050186633Abstract: A system utilizing cell immobilization in anaerobic continuous-flow cultures for modelling the gastrointestinal system is described. Microbial cells derived from flora, e.g. in fresh faecal samples, are used as the source of inocula for immobilisation in a mixed gel of gellan and xanthan. The beads produced are then introduced in a single or multi-stage chemostat fed with a nutrient media, and the composition and metabolic activities of the flora are monitored over time in reactors operated with conditions simulating the characteristics of different segments of the gastrointestinal tract. The conditions of this intestinal fermentation model are more akin to that for the gastrointestinal system, in which cells are naturally in the immobilized state, entrapped in fibrous particles or forming biofilms on the intestine epithelium. A use of such a system for studying various aspects of the gastrointestinal tract is also described.Type: ApplicationFiled: May 14, 2003Publication date: August 25, 2005Inventors: Christophe Lacroix, Gwenaelle LeBlay, Cecile Cinquin, Ismail Fliss
-
Publication number: 20040101906Abstract: A system utilizing cell immobilization in anaerobic continuous-flow cultures for modelling the gastrointestinal system is described. Microbial cells derived from flora, e.g. in fresh faecal samples, are used as the source of inocula for immobilisation in a mixed gel of gellan and xanthan. The beads produced are then introduced in a single or multi-stage chemostat fed with a nutrient media, and the composition and metabolic activities of the flora are monitored over time in reactors operated with conditions simulating the characteristics of different segments of the gastrointestinal tract. The conditions of this intestinal fermentation model are more akin to that for the gastrointestinal system, in which cells are naturally in the immobilized state, entrapped in fibrous particles or forming biofilms on the intestine epithelium. A use of such a system for studying various aspects of the gastrointestinal tract is also described.Type: ApplicationFiled: May 14, 2003Publication date: May 27, 2004Inventors: Christophe Lacroix, Gwenaelle LeBlay, Cecile Cinquin, Ismail Fliss
-
Publication number: 20040023360Abstract: A method and a system is disclosed for the modulation of various characteristics of probiotic cells and for the production of probiotics having altered characteristics. Such altered characteristics include increased resistance to various stresses, drugs and chemical agents, as well as aggregation. Such a method and a system are useful for the production of probiotics with altered characteristics, which may for example provide health benefits when present in the gastrointestinal tract of an animal.Type: ApplicationFiled: May 14, 2003Publication date: February 5, 2004Inventors: Christophe Lacroix, Ismail Fliss, Yann Doleyres, Dirk Bergmaier